Verily, the life sciences company owned by Google parent Alphabet, has partnered with Novartis, Sanofi, Otsuka, and Pfizer on a project that aims to speed up clinical trials. The pharma companies will use Verily’s clinical research tools- known as Project Baseline – to try to improve the recruitment of patients into clinical trials and make studies faster and more efficient. (pharmaforum)